Concepedia

Megan Manuel

MM

8

Publications

378

Citations

8

H-Index

2013

Active since

Affiliations

Atrium Health Wake Forest Baptist(Current)

Wake Forest University

Megan Manuel is an author at Atrium Health Wake Forest Baptist specializing in medicine, oncology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2013–2022

8

Publications

8

A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies

Timothy S. Pardee, King Lee, John Luddy et al. · Clinical Cancer Research · 2014 · 112 citations · Full text

A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna et al. · Clinical Cancer Research · 2018 · 102 citations · Full text

Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)

Bernard Tawfik, Sarunas Sliesoraitis, Susan Lyerly et al. · Annals of Hematology · 2013 · 59 citations

, , +8

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia

Rebecca G. Anderson, Lance D. Miller, Scott Isom et al. · Nature Communications · 2022 · 40 citations · Full text

High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly

Tamjeed Ahmed, Scott Holwerda, Heidi D. Klepin et al. · Leukemia Research · 2015 · 25 citations · Full text

, , +6

Rows per page

1–5 of 8